March 18, 2026 a 09:01 pm
GEHC: Analysts Ratings - GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. shows a mixed outlook with a strong presence in the healthcare sector. The analyst sentiment suggests a cautious optimism, with a relatively balanced distribution of recommendations. The outlook for growth depends largely on the company's ability to innovate and capture market share in its diverse operational segments.
Historical Stock Grades
| Rating Type | Count | Score Visualization |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 11 | |
| Hold | 6 | |
| Sell | 1 | |
| Strong Sell | 0 |
Sentiment Development
The sentiment surrounding GE HealthCare Technologies Inc. has shown some fluctuations over the past months. While the number of "Strong Buy" ratings has remained constant, the "Buy" category has seen some volatility. The "Hold" ratings have increased slightly, indicating growing caution among analysts:
- "Strong Buy" remained constant over the past months.
- "Buy" saw a slight decrease from 13 to 11 in recent data.
- "Hold" experienced a gradual increase, indicating caution.
Percentage Trends
The percentage distribution of analyst ratings provides insights into shifting market confidence. A slight decline in "Buy" recommendations against a steady "Strong Buy" indicates more conservative sentiment:
- Strong Buy: Consistently around 15%.
- Buy: Decreased slightly from 65% to 55%.
- Hold: Increased from 20% to 30%, suggesting a cautious market.
This shift suggests a trend towards more conservative investment strategies among analysts in recent months.
Latest Analyst Recommendations
Recent analyst recommendations have predominantly maintained existing positions, reflecting market stability:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-03-11 | Neutral | Neutral | Citigroup |
| 2026-02-09 | Buy | Buy | BTIG |
| 2026-02-06 | Equal Weight | Equal Weight | Barclays |
| 2026-02-05 | Outperform | Outperform | Evercore ISI Group |
| 2026-02-05 | Equal Weight | Equal Weight | Morgan Stanley |
Analyst Recommendations with Change of Opinion
Changes in analyst opinions highlight market volatility and evolving perceptions of GE HealthCare Technologies Inc.:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-01-15 | Sell | Neutral | UBS |
| 2025-10-07 | Neutral | Buy | Citigroup |
| 2025-05-05 | Neutral | Sell | UBS |
| 2025-03-11 | Buy | Neutral | Goldman Sachs |
| 2025-01-08 | Buy | Hold | Jefferies |
Interpretation
The current analyst sentiment suggests a cautious yet optimistic view towards GE HealthCare Technologies Inc. While there have been some downgrades, the majority of analysts maintain a neutral to positive outlook, indicating a stable market perception. The notable increase in "Hold" ratings could imply a temporary uncertainty or a wait-and-see approach. Changes in "Sell" and "Neutral" ratings suggest there are both challenges and opportunities ahead.
Conclusion
GE HealthCare Technologies Inc. presents a mixed investment outlook. While there is sustained confidence in its market potential, evident from consistent "Buy" ratings, there is a notable shift towards neutrality as suggested by the increase in "Hold" recommendations. This may reflect broader economic uncertainties or competitive pressures in the healthcare technology sector. Monitoring upcoming product developments and market expansions will be crucial in assessing future performance. Analysts remain cautiously optimistic, balancing potential growth with industry challenges.